PubMed HealthSearch

PubMed · 9068885

Epilepsy surgery.

Abstract

Surgical therapy of epilepsy, although still underutilized, is presently well accepted and performed world-wide with increasing frequency. In the last decade the following changes have been noticed: non-invasive pre-surgical evaluation is increasingly carried out in close collaboration with referring centres so that often no (or only a very short) hospitalization is necessary in highly specialized epilepsy centres for this purpose. Stereoelectro-encephalography (SEEG) is used less often in invasive evaluation while the subdural strip and grid electrode-techniques are used more often. There is a general trend for a more flexible and collaborative multidisciplinary and multi-method approach utilizing the whole spectrum of modern diagnostic facilities in a more patient-oriented and therefore more cost-effective way. The main objective of the pre-surgical evaluation is to determine the onset area of the patient's spontaneous habitual seizures. The primary epileptogenic zone is not necessarily synonymous with the so-called lesional zone, although in the great majority of patients they are related. In a small percentage of candidates for epilepsy surgery additional special examinations are necessary to prevent and/or predict the degree of post-operative deficits. At present selective Amytal tests are often used but these invasive procedures might be replaced in the future by functional PET and functional MR studies. Surgery in patients with epilepsy can be categorized into: (i) lesion-oriented surgery (lesionectomy sensu stricto), (ii) epilepsy-oriented lesional surgery, (iii) surgery for epilepsy sensu stricto. Surgery is performed with a 'curative (= causal)' or a 'palliative' intention. Furthermore surgery can be categorized into standardized epilepsy surgery (such as anterior temporal lobe resection, selective amygdalohippeocampectomy, anterior callosotomy); and individually tailored surgical interventions. It is obvious that also so-called standardized operations are tailored to some degree, usually based on pre-operative findings as well as on intraoperative corticography and/or other intra-operative neurophysiological tests (functional mapping). Individually tailored operations comprise smaller topectomies and larger resections. Surgery for temporal lobe epilepsy still prevails. For mesial temporal lobe epilepsy more selective operations, such as the selective amygdalohippocampectomy, are increasingly performed. Today the majority of patients suffering from this syndrome can be evaluated non-invasively (or 'semi-invasively' with the foramen ovale electrode technique) in combination with MRI (including volumetry of the hippocampus) and PET or SPECT. In general one has the impression that extratemporal resections without a lesion are performed less often. But, if a morphological abnormality is present, pre-surgical evaluation (using grids), and surgery making use of 'functional mapping' are increasingly offered from more and more centres. Anterior callosal sections and functional hemispherectomies have also witnessed a renaissance. The most important standardized operations are reviewed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H G Wieser. 1996. Epilepsy surgery.. https://pubmed.ncbi.nlm.nih.gov/9068885/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Excitotoxic basolateral amygdala lesions potentiate the memory impairment effect of muscimol injected into the medial septal area.

In rats, the septo-hippocampal system is important for memory encoding. Previous reports indicate that muscimol, a specific GABAergic agonist induces learning and memory deficits when infused into the medial septal area. The basolateral nucleus of the amygdala (BLA) modulates memory encoding in other brain areas, including the hippocampus. To explore the interactions between the septo-hippocampal system and amygdala in memory, we studied the effects of intra-medial septal infusions of muscimol in rats with BLA lesions. Animals received sham surgery or excitotoxic BLA lesions and were given infusions of either vehicle or muscimol (5 nmol) into the medial septal area 5 min prior to training sessions in inhibitory avoidance and water maze tasks. In the inhibitory avoidance task, muscimol-induced memory impairment was potentiated by BLA amygdala lesions. Additionally, in the water maze task, BLA-lesioned rats given muscimol infusions into the medial septal also showed memory impairment. These findings indicate that the MSA interacts with the BLA in the processing of memory storage.

Amygdala

Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus.

The stress-related neurohormone, corticotropin-releasing factor (CRF), also acts as a neurotransmitter to activate the brain noradrenergic nucleus, locus coeruleus (LC). Previous electrophysiological findings demonstrating that tonic CRF secretion in the LC is increased in adrenalectomized rats suggest that activity of certain CRF afferents to the LC is under inhibitory regulation by endogenous corticosteroids. The present study was designed to identify putative CRF afferents to the LC that may be regulated by glucocorticoids. Retrograde tract tracing from the rat LC and pericoerulear regions was combined with immunohistochemistry to visualize CRF and glucocorticoid receptors in the same sections of rat brain. The retrograde tracer, wheat germ agglutinin conjugated to horseradish peroxidase coupled to gold (WGA-Au-HRP) was injected into either the nucleus LC or the rostrolateral pericoerulear region (peri-LC), where CRF-immunoreactive terminals have been demonstrated to synapse with LC dendrites. Sections were processed to visualize the tracer, as well as CRF- and glucocorticoid receptor-immunoreactivity. Following injections of WGA-Au-HRP into the nuclear LC, triple labeled neurons were observed primarily in Barrington's nucleus, where 74+/-4% of retrogradely labeled CRF-immunoreactive neurons colocalized glucocorticoid receptor immunoreactivity. In contrast, injections that incorporated the rostrolateral peri-LC retrogradely labeled numerous neurons that were immunoreactive for both CRF and glucocorticoid receptors in the central nucleus of the amygdala. Thus, 94+/-2% of the retrogradely labeled CRF-immunoreactive neurons in the central nucleus of the amygdala colocalized glucocorticoid receptor immunoreactivity. Additionally, triple labeled neurons were observed in the bed nucleus of the stria terminalis following WGA-Au-HRP injections that incorporated the rostrolateral peri-LC. The present results implicate Barrington's nucleus, the central nucleus of the amygdala and the bed nucleus of the stria terminalis as glucocorticoid-sensitive sources of CRF that can influence the LC-noradrenergic system. Alterations in glucocorticoid levels or glucocorticoid receptor function would be predicted to affect the impact of these specific CRF systems on LC activity.

Amygdala

Reduction of voltage-dependent currents by ethanol contributes to inhibition of NMDA receptor-mediated excitatory synaptic transmission.

Previous studies have shown inhibitory effects of EtOH on NMDA receptor-mediated synaptic transmission in several brain regions. We examined this effect of EtOH under both current clamp and voltage clamp conditions in the basolateral amygdala because of the putative role of the amygdala in mediating anxiolytic effects of EtOH. We found that EtOH reduced NMDA receptor-mediated synaptic responses. In addition, we found that NMDA receptor-mediated depolarizations could also activate a voltage-dependent regenerative potential which was also sensitive to EtOH. Pharmacological characterization of this current was consistent with a high-threshold Ca2+ current. This current also exhibited a pronounced tendency towards transient enhancement upon withdrawal of EtOH.

Amygdala